Baxter International Inc
A maker of essential hospital supplies, Baxter produces sterile IV solutions, infusion pumps, parenteral nutrition, surgical sealants, smart beds, and patient monitors sold in dozens of countries. Founded in 1931 by Dr. Donald Baxter and surgeon Ralph Falk, the company created the first factory-made sterile IV solutions in vacuum-sealed glass containers, replacing the contaminated hand-mixed fluids hospitals once brewed themselves. In 2025 it sold its Kidney Care business, Vantive.
Granted 1.8K · Sold 28.90M
Granted 1.97M · Sold 1.33M
Granted 569.9K
Granted 776.2K · Bought 11.7K
Granted 301.5K
Granted 663.4K · Sold 395.5K
Granted 221.7K
Granted 165.5K
Granted 422.4K · Sold 415.3K
Granted 11.3K
Granted 170.5K
Granted 128.7K
Granted 401.7K · Sold 251.8K
Granted 128.5K
Granted 198.4K · Sold 84.4K
Granted 192.8K · Sold 71.3K
Granted 225.4K
Granted 149.6K · Sold 46.6K
Granted 213.6K · Bought 5.0K · Sold 159.9K
Granted 83.2K
Granted 128.3K · Sold 47.5K
Granted 261.4K · Sold 169.6K
Granted 26.0K
Granted 102.1K
Granted 84.3K
Granted 355.1K · Sold 290.1K
Granted 125.8K · Sold 46.4K
Granted 76.4K · Sold 2.5K
Granted 61.4K
Granted 479.9K · Sold 434.8K
Granted 126.3K · Sold 110.3K
Granted 152.1K · Bought 9.8K · Sold 88.3K
Granted 249.4K · Sold 197.4K
Granted 19.6K
Granted 1.0K
Granted 70.2K · Sold 62.7K
Granted 38.6K
Granted 69.3K
Granted 40.5K
Granted 98.9K · Sold 72.2K
Granted 77.4K · Bought 696 · Sold 45.3K
Granted 35.8K
Granted 33.6K
Granted 14.8K
Granted 34.0K
Granted 9.2K
Granted 76.6K · Sold 52.3K
Granted 15.5K
Granted 64.4K · Bought 560 · Sold 37.5K
Granted 69.7K · Sold 35.1K
Granted 19.0K
Granted 29.8K
Granted 28.7K
Granted 29.8K
Granted 97.2K · Sold 74.0K
Granted 72.4K · Sold 47.6K
Granted 16.1K
Granted 72.3K · Sold 48.1K
Granted 77.8K · Sold 70.4K
Granted 23.1K · Sold 1.7K
Granted 30.6K · Sold 22.7K
Granted 23.5K
Granted 21.3K
Granted 13.6K
Granted 35.1K · Sold 15.7K
Granted 63.4K · Sold 45.6K
Granted 39.8K · Sold 18.1K
Granted 24.6K · Bought 1.5K · Sold 11.5K
Granted 16.2K
Granted 28.2K · Sold 15.8K
Granted 74.2K · Sold 70.8K
Granted 14.6K
Granted 13.0K
Granted 8.0K
Granted 12.1K
Granted 21.1K · Sold 14.8K
Granted 8.1K
Granted 23.8K · Sold 21.6K
Granted 29.7K
Granted 790
Granted 1.8K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Loeb Daniel S +1 co-filerDirector · 7 transactions | — | 23.01Mas of May 2019 | 1.8K | — | 28.90M |
| Parkinson Robert L JrChairman of the Board and CEO, Director · 40 transactions | — | 690.0Kas of Aug 2015 | 1.97M | — | 1.33M |
| Hider Andrew P.President and CEO, Director · 3 transactions | — | 572.2K | 569.9K | — | — |
| Almeida Jose EChairman, CEO, President · 32 transactions | — | 568.6Kas of Dec 2024 | 776.2K | 11.7K | — |
| Grade Joel T.EVP and CFO · 12 transactions | — | 271.7K | 301.5K | — | — |
| Mason Jeanne KEVP, Chief HR Officer · 89 transactions | — | 199.9K | 663.4K | — | 395.5K |
| Saccaro JamesEVP, Chief Financial Officer · 33 transactions | — | 177.9Kas of Mar 2023 | 221.7K | — | — |
| Knight HeatherEVP, Chief Operating Officer · 13 transactions | — | 177.4Kas of Mar 2025 | 165.5K | — | — |
| Gatling James MCorporate Vice President · 64 transactions | — | 163.1Kas of Jan 2011 | 422.4K | — | 415.3K |
| Utts James ECorporate Vice President · 3 transactions | — | 142.8Kas of Mar 2006 | 11.3K | — | — |
| Rosenbloom David S.EVP and General Counsel · 16 transactions | — | 138.2K | 170.5K | — | — |
| Sonig AlokEVP,Group President,Pharma · 9 transactions | — | 128.2K | 128.7K | — | — |
| Davis Robert MCorporate Vice President · 47 transactions | — | 125.9Kas of Jan 2014 | 401.7K | — | 251.8K |
| Rasul ReazurEVP,Group Pres,Healthcare · 11 transactions | — | 125.6K | 128.5K | — | — |
| Scharf David P.CVP and General Counsel · 33 transactions | — | 112.3Kas of Feb 2017 | 198.4K | — | 84.4K |
| Hantson LudwigCorporate Vice President · 24 transactions | — | 110.0Kas of Jun 2015 | 192.8K | — | 71.3K |
| Toth Christopher A.EVP, Group Pres, Kidney Care · 5 transactions | — | 105.2Kas of Jan 2025 | 225.4K | — | — |
| Franzi CristianoSVP, President, EMEA · 24 transactions | — | 102.1Kas of Mar 2023 | 149.6K | — | 46.6K |
| Greisch John JCorporate Vice President · 162 transactions | — | 85.5Kas of Mar 2009 | 213.6K | 5.0K | 159.9K |
| Amundson Joy ACorporate Vice President · 15 transactions | — | 81.7Kas of Mar 2010 | 83.2K | — | — |
| Hombach Robert J.Corporate Vice President · 20 transactions | — | 81.0Kas of Mar 2015 | 128.3K | — | 47.5K |
| Accogli GiuseppeEVP, Chief Operating Officer · 52 transactions | — | 76.5Kas of Mar 2022 | 261.4K | — | 169.6K |
| Soriano Maria CeciliaGroup Pres., ITT & Pharma. · 5 transactions | — | 75.0K | 26.0K | — | — |
| Shafer David BrentDirector, Chair of the Board · 6 transactions | — | 72.8K | 102.1K | — | — |
| Borzi James WEVP,Chief Supply Chain Officer · 16 transactions | — | 71.9K | 84.3K | — | — |
| Eyre Brik VSVP, President, Americas · 43 transactions | — | 71.5Kas of Feb 2019 | 355.1K | — | 290.1K |
| Wallace Steven P.President, Adv. Surgery · 1 transaction | — | 70.1K | — | — | — |
| Arduini Peter JCorporate Vice President · 18 transactions | — | 69.0Kas of Mar 2010 | 125.8K | — | 46.4K |
| Stevens BrianSVP, CAO & Controller · 36 transactions | — | 67.5Kas of Mar 2024 | 76.4K | — | 2.5K |
| Zielinski Anita ASVP, Interim CFO, CAO & Cntrlr · 4 transactions | — | 59.7K | 61.4K | — | — |
| Riedel Norbert GCorporate Vice President · 40 transactions | — | 58.6Kas of Jan 2013 | 479.9K | — | 434.8K |
| Stallkamp Thomas TDirector · 47 transactions | — | 56.8Kas of May 2021 | 126.3K | — | 110.3K |
| Martin SeanSVP and General Counsel · 27 transactions | — | 52.6Kas of Mar 2022 | 152.1K | 9.8K | 88.3K |
| McGillivray BruceCorporate Vice President · 42 transactions | — | 52.6Kas of Mar 2010 | 249.4K | — | 197.4K |
| Vibert PaulCVP, International · 15 transactions | — | 51.3Kas of Mar 2017 | 19.6K | — | — |
| Schaaf Jill MCVP, Renal · 10 transactions | — | 48.6Kas of Mar 2016 | 1.0K | — | — |
| Storm Kornelis J.Director · 25 transactions | — | 45.3Kas of Mar 2018 | 70.2K | — | 62.7K |
| Wendell Amy McBrideDirector · 10 transactions | — | 44.2K | 38.6K | — | — |
| Butel Jean LucCorporate Vice President · 6 transactions | — | 42.7Kas of Dec 2014 | 69.3K | — | — |
| Morrison PatriciaDirector · 9 transactions | — | 42.4K | 40.5K | — | — |
| Gavin James R IIIDirector · 40 transactions | — | 39.5Kas of Aug 2020 | 98.9K | — | 72.2K |
| Stroucken Albert P LDirector · 47 transactions | — | 38.2Kas of Mar 2023 | 77.4K | 696 | 45.3K |
| Wilkes David S.Director · 7 transactions | — | 37.1K | 35.8K | — | — |
| Oesterle Stephen N.Director · 10 transactions | — | 35.8Kas of May 2025 | 33.6K | — | — |
| Schabacker MarcusCVP, Chief Scientific Officer · 16 transactions | — | 35.6Kas of Mar 2017 | 14.8K | — | — |
| Schlichting Nancy MDirector · 6 transactions | — | 35.0K | 34.0K | — | — |
| Lawrence Timothy PCVP, Operations · 11 transactions | — | 34.5Kas of Mar 2016 | 9.2K | — | — |
| Fosler Gail DDirector · 20 transactions | — | 32.6Kas of May 2015 | 76.6K | — | 52.3K |
| Felicelli RobertCVP, Business Transformation · 11 transactions | — | 32.5Kas of Jun 2016 | 15.5K | — | — |
| Hellman Peter SDirector · 39 transactions | — | 31.5Kas of May 2022 | 64.4K | 560 | 37.5K |
| White Cheryl LCorporate Vice President · 22 transactions | — | 31.4Kas of Mar 2010 | 69.7K | — | 35.1K |
| Flynn StevenSVP, President, APAC · 3 transactions | — | 31.1Kas of Mar 2023 | 19.0K | — | — |
| Teaff JamesPresident, CCS · 1 transaction | — | 31.1K | — | — | — |
| Ampofo William A. IIDirector · 4 transactions | — | 30.4K | 29.8K | — | — |
| Smith Cathy RDirector · 9 transactions | — | 30.3Kas of May 2025 | 28.7K | — | — |
| Mahoney Michael FDirector · 10 transactions | — | 30.1Kas of May 2023 | 29.8K | — | — |
| Baughman Michael JCorporate Vice President · 25 transactions | — | 30.0Kas of Jan 2013 | 97.2K | — | 74.0K |
| Pleau ScottSVP, Operations · 13 transactions | — | 29.8Kas of Mar 2019 | 72.4K | — | 47.6K |
| Rasul ReazEVP, Group Pres, Healthcare · 6 transactions | — | 27.9Kas of Feb 2024 | 16.1K | — | — |
| Forsyth John DDirector · 56 transactions | — | 27.0Kas of Apr 2022 | 72.3K | — | 48.1K |
| Boomer Walter EDirector · 23 transactions | — | 25.0Kas of May 2011 | 77.8K | — | 70.4K |
| Chen Thomas FDirector · 15 transactions | — | 24.9Kas of May 2022 | 23.1K | — | 1.7K |
| Batchelor Phillip L.Corporate Vice President · 16 transactions | — | 24.6Kas of Jan 2014 | 30.6K | — | 22.7K |
| Craig Jeffrey ADirector · 3 transactions | — | 23.7K | 23.5K | — | — |
| Lichtenstein Susan RCorporate Vice President · 10 transactions | — | 23.2Kas of Mar 2009 | 21.3K | — | — |
| Terrell Karenann KCorporate Vice President · 10 transactions | — | 22.8Kas of Mar 2010 | 13.6K | — | — |
| Kunzler JacquelineSVP, Chief Quality Officer · 29 transactions | — | 22.6Kas of Mar 2023 | 35.1K | — | 15.7K |
| Bufalino Sebastian JCVP, Controller · 26 transactions | — | 22.2Kas of Mar 2016 | 63.4K | — | 45.6K |
| Frye AndrewSVP, President, APAC · 15 transactions | — | 22.0Kas of Mar 2022 | 39.8K | — | 18.1K |
| Devitt Blake EDirector · 16 transactions | — | 19.9Kas of May 2015 | 24.6K | 1.5K | 11.5K |
| Rusckowski Stephen HDirector · 3 transactions | — | 16.5Kas of May 2025 | 16.2K | — | — |
| Storm Kees JDirector · 22 transactions | — | 16.2Kas of May 2014 | 28.2K | — | 15.8K |
| Shapazian Carole JDirector · 39 transactions | — | 16.0Kas of Dec 2018 | 74.2K | — | 70.8K |
| McDonnell Michael R.Director · 2 transactions | — | 14.6K | 14.6K | — | — |
| Wilver Peter MDirector · 3 transactions | — | 13.3Kas of May 2024 | 13.0K | — | — |
| Karp CarolineSVP, Controller · 10 transactions | — | 12.6Kas of Mar 2018 | 8.0K | — | — |
| Hockmeyer Wayne TDirector · 9 transactions | — | 12.4Kas of May 2015 | 12.1K | — | — |
| Shapazian Carole J UhrichDirector · 11 transactions | — | 11.0Kas of Nov 2010 | 21.1K | — | 14.8K |
| Chowdhry UmaDirector · 6 transactions | — | 9.9Kas of May 2016 | 8.1K | — | — |
| Martin Joseph BDirector · 26 transactions | — | 8.6Kas of Oct 2010 | 23.8K | — | 21.6K |
| Carlisle CynthiaExecutive Vice President, CHRO · 2 transactions | — | 0 | 29.7K | — | — |
| Chen Thomas Fang-TyanDirector · 1 transaction | — | 0as of Nov 2012 | 790 | — | — |
| Islam MunibDirector · 1 transaction | — | 0as of Oct 2015 | 1.8K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -33.79M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.